Yuan Jiandong is a Chinese businessman, the Chairman of Shanghai-listed BrightGene Bio-Medical Technology (SHA: 688166), a major pharmaceutical supplier.

Yuan is highly educated, holding an undergraduate degree in chemicals from Peking University and a Ph.D. in chemistry from the State University of New York. He gained international experience working for Enzo Biochem in the U.S. after graduation from 1998 to April 2001. He returned to China and founded BrightGene in 2001.

• Core Company: BrightGene Bio-Medical Technology (Pharmaceutical supplier).
• Founding: Returned to China and founded BrightGene in 2001.
• Education: Holds a Ph.D. in chemistry from the State University of New York.

Yuan Jiandong's career is defined by his successful move from international R&D to domestic entrepreneurship. His structural achievement is tied to establishing BrightGene as a leading supplier in the Chinese pharmaceutical market, leveraging his deep technical expertise.

His experience at Enzo Biochem in the U.S. provided crucial industry insight before he returned to found his own company.

• Prior Role: Worked for Enzo Biochem in the U.S. from 1998 to April 2001.